Exact Mass: 420.1896
Exact Mass Matches: 420.1896
Found 264 metabolites which its exact mass value is equals to given mass value 420.1896
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Ocaperidone
C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Ocaperidone is an effective antipsychotic agent, acting as a potent 5-HT2 and dopamine D2 antagonist, and a 5-HT1A agonist, with Kis of 0.14 nM, 0.46 nM, 0.75 nM, 1.6 nM and 5.4 nM for 5-HT2, a1-adrenergic receptor, dopamine D2, histamine H1 and a2-adrenergic receptor, respectively, and a pEC50 and pKi of 7.60 and 8.08 for h5-HT1A.
Predef
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid Same as: D04627
Kanzonol F
Kanzonol F is found in herbs and spices. Kanzonol F is a constituent of Glycyrrhiza uralensis (Chinese licorice). Constituent of Glycyrrhiza uralensis (Chinese licorice). Kanzonol F is found in herbs and spices.
Murrastifoline F
Murrastifoline F is found in herbs and spices. Murrastifoline F is an alkaloid from roots of Murraya koenigii (curryleaf tree). Alkaloid from roots of Murraya koenigii (curryleaf tree). Murrastifoline F is found in herbs and spices.
Bay-41-8543
Isoflupredone acetate
Erypoegin J
4-Methoxy-7-O-[(E)-3-methyl-7-hydroxymethyl-2,6-octadienyl]isoflavone
Burttinonedehydrate
aminophylline
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03D - Other systemic drugs for obstructive airway diseases > R03DA - Xanthines D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor D020011 - Protective Agents > D002316 - Cardiotonic Agents D002317 - Cardiovascular Agents Aminophylline is a competitive and non-selective phosphodiesterase (PDE) inhibitor. Aminophylline is a competitive adenosine receptor antagonist. Aminophylline has apulmonary vasodilator action as well as a bronchodilator action and has the potential for asthma research[1][2].
5,7,3,4-Tetrahydroxy-2,5-di(3-methylbut-2-enyl)isoflavone
5-hydroxy-4-methoxy-7-O-geranyl isoflavone|7-O-geranylbiochanin A
5-Hydroxy-7-methoxy-3-(4-hydroxyphenyl)-6,8-bis(3-methyl-2-butenyl)-4H-1-benzopyran-4-one
5,7-dihydroxy-4-methoxy-3-(3-methylbutadienyl)-5-(3-methylbut-2-enyl)flavanone|burttinonedehydrate
3-(4-Methoxyphenyl)-5,7-dihydroxy-6,8-diprenyl-4H-1-benzopyran-4-one
8-(3,4-Dihydro-5-methoxy-8,8-dimethyl-2H,8H-benzo[1,2-b:3,4-b]dipyran-3-yl)-2,2-dimethyl-2H-1-benzopyran-5-ol
8-formyl-3,9-dihydroxy-4,10-diprenylpterocarpan|erylysin C
3alpha,5beta,6alpha-trihydroxy-4alpha-(beta-D-glucopyranosyloxy)-7-megastigmen-9-one|youngiajaponicoside C
GLYCYRRHIZOL A
A member of the class of coumestans that is 3,4-didehydroterocarpan substituted by hydroxy groups at positions 7 and 4, a methoxy group at position 5 and prenyl groups at positions 6 and 5. Isolated from the roots of Glycyrrhiza uralensis, it exhibits antibacterial activity.
Schizokinen
A hydroxamic acid resulting from the formal condensation of the primary amino group of N-(3-aminopropyl)-N-hydroxyacetamide (2 mol eq.) with the carboxy groups at positions 1 and 3 of citric acid. It is a siderophore produced by Bacillus megaterium and Anabaena species.
BAY-41-8543
Val Ser Thr Asp
H6JQH0051J
Ala Glu Thr Thr
Ala Gly His His
Ala His Gly His
Ala His His Gly
Ala Thr Glu Thr
Ala Thr Thr Glu
Asp Ile Ser Ser
Asp Leu Ser Ser
Asp Ser Ile Ser
Asp Ser Leu Ser
Asp Ser Ser Ile
Asp Ser Ser Leu
Asp Ser Thr Val
Asp Ser Val Thr
Asp Thr Ser Val
Asp Thr Val Ser
Asp Val Ser Thr
Asp Val Thr Ser
Glu Ala Thr Thr
Glu Ser Ser Val
Glu Ser Val Ser
Glu Thr Ala Thr
Glu Thr Thr Ala
Glu Val Ser Ser
Gly Ala His His
Gly His Ala His
Gly His His Ala
His Ala Gly His
His Ala His Gly
His Gly Ala His
His Gly His Ala
His His Ala Gly
His His Gly Ala
Ile Asp Ser Ser
Ile Ser Asp Ser
Ile Ser Ser Asp
Leu Asp Ser Ser
Leu Ser Asp Ser
Leu Ser Ser Asp
Ser Asp Ile Ser
Ser Asp Leu Ser
Ser Asp Ser Ile
Ser Asp Ser Leu
Ser Asp Thr Val
Ser Asp Val Thr
Ser Glu Ser Val
Ser Glu Val Ser
Ser Ile Asp Ser
Ser Ile Ser Asp
Ser Leu Asp Ser
Ser Leu Ser Asp
Ser Ser Asp Ile
Ser Ser Asp Leu
Ser Ser Glu Val
Ser Ser Ile Asp
Ser Ser Leu Asp
Ser Ser Val Glu
Ser Thr Asp Val
Ser Thr Val Asp
Ser Val Asp Thr
Ser Val Glu Ser
Ser Val Ser Glu
Ser Val Thr Asp
Thr Ala Glu Thr
Thr Ala Thr Glu
Thr Asp Ser Val
Thr Asp Val Ser
Thr Glu Ala Thr
Thr Glu Thr Ala
Thr Ser Asp Val
Thr Ser Val Asp
Thr Thr Ala Glu
Thr Thr Glu Ala
Thr Val Asp Ser
Thr Val Ser Asp
Val Asp Ser Thr
Val Asp Thr Ser
Val Glu Ser Ser
Val Ser Asp Thr
Val Ser Glu Ser
Val Ser Ser Glu
Val Thr Asp Ser
Val Thr Ser Asp
Idebenone Metabolite (1,4-Benzenediol, 2-(10-hydroxydecyl)-5,6-dimethoxy-3-methyl-, 4-(hydrogen sulf
Kanzonol F
4,4-Bis[2-(3-methoxyphenyl)ethenyl]-2,2-bipyridine
Beraprost sodium
D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents C78568 - Prostaglandin Analogue
(E,E)-4,4-Bis[2-(4-methoxyphenyl)ethenyl]-2,2-bipyridine
N-[2-(1,3-Benzodioxol-5-Yl)ethyl]-1-[2-(1h-Imidazol-1-Yl)-6-Methylpyrimidin-4-Yl]-D-Prolinamide
N-{2-[(4-Fluorophenyl)amino]-4,4-Bipyridin-2-Yl}-4-Methoxycyclohexanecarboxamide
N~4~-Methyl-N~4~-(3-Methyl-1h-Indazol-6-Yl)-N~2~-(3,4,5-Trimethoxyphenyl)pyrimidine-2,4-Diamine
5-[[4-(4-Morpholinylmethyl)anilino]methylidene]-1-(phenylmethyl)-1,3-diazinane-2,4,6-trione
4-[[4-(1,3-Benzodioxol-5-ylmethyl)-1-piperazinyl]-oxomethyl]-2-ethyl-1-phthalazinone
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-methoxyacetamide
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-methoxyacetamide
N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-methoxyacetamide
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-methoxyacetamide
N-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-methoxyacetamide
(6S,7R,8R)-7-[4-(1-cyclopentenyl)phenyl]-4-[(3-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-methoxyacetamide
N-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-methoxyacetamide
N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-methoxyacetamide
(6R,7R,8R)-7-[4-(1-cyclopentenyl)phenyl]-4-[(3-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
6-hydroxy-10,13-dimethyl-7-methylsulfinylspiro[2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17,5-oxolane]-2,3-dione
10,13-dimethyl-7-methylsulfonylspiro[2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17,5-oxolane]-2,3-dione
1,3,5-Pentanetricarboxylic acid tris(trimethylsilyl) ester
4,6-Pyrimidinediamine, 2-(1-((2-fluorophenyl)methyl)-1H-pyrazolo(3,4-b)pyridin-3-yl)-5-(4-morpholinyl)-
BisMePA(14:2)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved